Kevin Koch

Insider Reports History

Entity
Individual
Location
3200 Walnut St, Boulder, CO
Signature
/s/John R. Moore Attorney-in-Fact for Kevin Koch
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Koch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Edgewise Therapeutics, Inc. President and CEO, Director Common Stock 260K $7.79M $30.00 Mar 7, 2025 KTK Family Enterprise, LLC
Edgewise Therapeutics, Inc. President and CEO, Director Restricted Stock Units 71.9K $1.36M $18.91 Aug 12, 2024 Direct
Edgewise Therapeutics, Inc. President and CEO, Director Common Stock 26.4K $792K $30.00 Mar 7, 2025 Adrienne R. Koch Heritage Trust
Edgewise Therapeutics, Inc. President and CEO, Director Common Stock 26.4K $792K $30.00 Mar 7, 2025 Matthew K. Koch Heritage Trust
Edgewise Therapeutics, Inc. President and CEO, Director Common Stock 26.4K $792K $30.00 Mar 7, 2025 Nicole M. Soldow Heritage Trust
Edgewise Therapeutics, Inc. President and CEO, Director Common Stock 14.5K $434K $30.00 Mar 7, 2025 Direct
Edgewise Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 41.5K Mar 7, 2025 Direct

Insider Reports Filed by Kevin Koch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EWTX Edgewise Therapeutics, Inc. Mar 7, 2025 3 -$2.98K 4 Mar 11, 2025 President and CEO, Director
EWTX Edgewise Therapeutics, Inc. Feb 5, 2025 6 -$274K 4 Feb 7, 2025 President and CEO, Director
EWTX Edgewise Therapeutics, Inc. Aug 12, 2024 2 $0 4 Aug 14, 2024 President and CEO, Director
EWTX Edgewise Therapeutics, Inc. May 1, 2024 3 -$59.6K 4 May 3, 2024 President and CEO, Director
EWTX Edgewise Therapeutics, Inc. Aug 17, 2023 1 $0 4 Aug 18, 2023 President and CEO, Director
EWTX Edgewise Therapeutics, Inc. May 1, 2023 3 -$28.5K 4 May 3, 2023 President and CEO, Director
EWTX Edgewise Therapeutics, Inc. Aug 8, 2022 1 $0 4 Aug 10, 2022 President and CEO, Director
EWTX Edgewise Therapeutics, Inc. May 1, 2022 1 $0 4 May 3, 2022 President and CEO, Director
EWTX Edgewise Therapeutics, Inc. Aug 17, 2021 1 $0 4 Aug 19, 2021 President and CEO, Director